Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
NEKTAR THERAPEUTICS has filed 1,955 SEC EDGAR filings since 14 Feb 1996

SEC filing history

Showing 51-75 of 1,000 matching filings.

Per page
25
Current page
3
4

4

Filing date
25 Nov 2025
Reporting date
21 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
25 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
25 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
25 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
21 Nov 2025
Reporting date
21 Nov 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-45385

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-45385

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-45385

SCHEDULE 13G filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-291471

REGISTRATION STATEMENT

Filing date
12 Nov 2025
Reporting date
Not listed
Next action
Verify source filing
424B5 File 333-286222

424B5

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
10 Nov 2025
Reporting date
08 Nov 2025
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
06 Nov 2025
Reporting date
06 Nov 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-45385

SCHEDULE 13G/A filing

Filing date
31 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-45385

SCHEDULE 13G/A filing

Filing date
28 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-24006

CURRENT REPORT

Filing date
18 Sep 2025
Reporting date
18 Sep 2025
Next action
Verify source filing
4

4

Filing date
11 Sep 2025
Reporting date
09 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-24006

144 filing

Filing date
09 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Sep 2025
Reporting date
04 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .